Français
Español
English
Portuguese
Oramed Pharmaceuticals is looking to revolutionize the treatment of diabetes with its oral insulin capsule, which stands to enter FDA-approved Phase 2 trials in the US. » Oramed Pharmaceuticals is looking to revolutionize the treatment of diabetes with its oral insulin capsule, which stands to enter FDA-approved Phase 2 trials in the US.
Oramed Pharmaceuticals is looking to revolutionize the treatment of diabetes with its oral insulin capsule, which stands to enter FDA-approved Phase 2 trials in the US.